Pregnancy and venous thromboembolism

Stefano Barco, Mathilde Nijkeuter, Saskia Middeldorp

Research output: Contribution to journalArticle

Abstract

Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been excluded from all major trials investigating different diagnostic tools and treatment regimens. Nevertheless, proper evaluation of the involved risk factors is mandatory to reduce the incidence of pregnancy-related VTE and improve outcomes. Low-molecular-weight heparins are considered as a first-line option in the management of pregnancy-related VTE. With regard to future research, there is a need for methodologically strong studies in pregnant women, especially with respect to risk stratification, optimal heparin doses, usefulness of anti-FXa levels and their correlation with clinical outcomes, and correct management of anticoagulation during delivery.

Original languageEnglish
Pages (from-to)549-558
Number of pages10
JournalSeminars in Thrombosis and Hemostasis
Volume39
Issue number5
DOIs
Publication statusPublished - 2013

Fingerprint

Venous Thromboembolism
Pregnancy
Pregnant Women
Low Molecular Weight Heparin
Developed Countries
Postpartum Period
Heparin
Mortality
Incidence

Keywords

  • anticoagulants
  • hemostasis
  • pregnancy
  • pulmonary embolism
  • venous thrombosis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Pregnancy and venous thromboembolism. / Barco, Stefano; Nijkeuter, Mathilde; Middeldorp, Saskia.

In: Seminars in Thrombosis and Hemostasis, Vol. 39, No. 5, 2013, p. 549-558.

Research output: Contribution to journalArticle

Barco, S, Nijkeuter, M & Middeldorp, S 2013, 'Pregnancy and venous thromboembolism', Seminars in Thrombosis and Hemostasis, vol. 39, no. 5, pp. 549-558. https://doi.org/10.1055/s-0033-1343893
Barco, Stefano ; Nijkeuter, Mathilde ; Middeldorp, Saskia. / Pregnancy and venous thromboembolism. In: Seminars in Thrombosis and Hemostasis. 2013 ; Vol. 39, No. 5. pp. 549-558.
@article{66c6fc18acde4c5f85963eda55568c9a,
title = "Pregnancy and venous thromboembolism",
abstract = "Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been excluded from all major trials investigating different diagnostic tools and treatment regimens. Nevertheless, proper evaluation of the involved risk factors is mandatory to reduce the incidence of pregnancy-related VTE and improve outcomes. Low-molecular-weight heparins are considered as a first-line option in the management of pregnancy-related VTE. With regard to future research, there is a need for methodologically strong studies in pregnant women, especially with respect to risk stratification, optimal heparin doses, usefulness of anti-FXa levels and their correlation with clinical outcomes, and correct management of anticoagulation during delivery.",
keywords = "anticoagulants, hemostasis, pregnancy, pulmonary embolism, venous thrombosis",
author = "Stefano Barco and Mathilde Nijkeuter and Saskia Middeldorp",
year = "2013",
doi = "10.1055/s-0033-1343893",
language = "English",
volume = "39",
pages = "549--558",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "5",

}

TY - JOUR

T1 - Pregnancy and venous thromboembolism

AU - Barco, Stefano

AU - Nijkeuter, Mathilde

AU - Middeldorp, Saskia

PY - 2013

Y1 - 2013

N2 - Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been excluded from all major trials investigating different diagnostic tools and treatment regimens. Nevertheless, proper evaluation of the involved risk factors is mandatory to reduce the incidence of pregnancy-related VTE and improve outcomes. Low-molecular-weight heparins are considered as a first-line option in the management of pregnancy-related VTE. With regard to future research, there is a need for methodologically strong studies in pregnant women, especially with respect to risk stratification, optimal heparin doses, usefulness of anti-FXa levels and their correlation with clinical outcomes, and correct management of anticoagulation during delivery.

AB - Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been excluded from all major trials investigating different diagnostic tools and treatment regimens. Nevertheless, proper evaluation of the involved risk factors is mandatory to reduce the incidence of pregnancy-related VTE and improve outcomes. Low-molecular-weight heparins are considered as a first-line option in the management of pregnancy-related VTE. With regard to future research, there is a need for methodologically strong studies in pregnant women, especially with respect to risk stratification, optimal heparin doses, usefulness of anti-FXa levels and their correlation with clinical outcomes, and correct management of anticoagulation during delivery.

KW - anticoagulants

KW - hemostasis

KW - pregnancy

KW - pulmonary embolism

KW - venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84879110047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879110047&partnerID=8YFLogxK

U2 - 10.1055/s-0033-1343893

DO - 10.1055/s-0033-1343893

M3 - Article

C2 - 23633191

AN - SCOPUS:84879110047

VL - 39

SP - 549

EP - 558

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 5

ER -